EFTA01453444.pdf
👁 1
💬 0
📄 Extracted Text (166 words)
1d chg (%) Index. WI (%)
BIOGEN IDEC INC -8.2 7.9
AMGEN INC -3.2 7.8
Gil F • n SCIENCES INC. -4.6 7.0
REGENERON PHARMACEUTICALS -5.4 6.9
CELGENE CORP -3.7 6.5
ALEXION PHARMACEUTICALS INC -8.0 4.6
ILLUMINA INC -5.4 4.6
MYLAN INC -0.9 4.3
VERTEX PHARMACEUTICALS INC -5.1 3.8
BIONMIN PHARMACEUTICAL INC -5.9 2.5
Ways to hedge exposure to the US biotech sector
• ProShares UltraShort Nasdaq Biotech Fund (BIS US Equity): designed to be 2x short the NBI
• Options on iSharesNasdaq Biotech ETF (IBB US Equity)
NBI — last 5 ears
300u
2577.21
2000
1500
1000
500
2009 2010 2011 2012 2013 201,
N kaccaq BlOteCh^t 'J4:4 Copyrighte 2014 alccenterg Finance L.V. 23-Mar-2014 14:3S:20
NBI vs S&P500 — last 1 year
60 "
Normalized As Of 03/23/2013
o• NBI Index - SPX Index 38..8807 is
)8.8807
20 •
0
Jun Sep Dec Mar
2013 2014
NBI — last 1 year
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 111026
CONFIDENTIAL SDNY_GM_00257210
EFTA01453444
ℹ️ Document Details
SHA-256
4986bc88f2a499fa09ed1dd8b80a849c13a1b4e73ad9018a3078f8e32393b067
Bates Number
EFTA01453444
Dataset
DataSet-10
Type
document
Pages
1
💬 Comments 0